Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Sittner & Nelson LLC

Sittner & Nelson LLC decreased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.6% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 934 shares of the medical equipment provider’s stock after selling 25 shares during the quarter. Sittner & Nelson LLC’s holdings in Intuitive Surgical were worth $459,000 as of its most recent filing with the SEC.

Several other hedge funds have also made changes to their positions in the business. TFB Advisors LLC lifted its position in Intuitive Surgical by 4.8% in the third quarter. TFB Advisors LLC now owns 1,718 shares of the medical equipment provider’s stock valued at $844,000 after purchasing an additional 79 shares during the period. Portside Wealth Group LLC lifted its position in Intuitive Surgical by 15.5% in the third quarter. Portside Wealth Group LLC now owns 1,165 shares of the medical equipment provider’s stock valued at $572,000 after purchasing an additional 156 shares during the period. Consolidated Planning Corp lifted its position in Intuitive Surgical by 17.4% in the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock valued at $3,979,000 after purchasing an additional 1,198 shares during the period. Valley Brook Capital Group Inc. acquired a new stake in Intuitive Surgical in the third quarter valued at about $236,000. Finally, Principal Financial Group Inc. lifted its position in Intuitive Surgical by 1.5% in the third quarter. Principal Financial Group Inc. now owns 602,393 shares of the medical equipment provider’s stock valued at $295,938,000 after purchasing an additional 9,194 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on ISRG shares. Robert W. Baird raised their price objective on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research report on Thursday, October 17th. Piper Sandler restated an “overweight” rating and issued a $538.00 price objective (up previously from $495.00) on shares of Intuitive Surgical in a research report on Friday, October 18th. Citigroup raised their price objective on shares of Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a research report on Thursday, August 22nd. Wells Fargo & Company lifted their price target on shares of Intuitive Surgical from $466.00 to $549.00 and gave the company an “overweight” rating in a research report on Friday, October 18th. Finally, Evercore ISI reiterated a “cautious” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $513.74.

Intuitive Surgical Price Performance

Shares of ISRG opened at $524.28 on Friday. The firm has a 50 day simple moving average of $492.30 and a 200-day simple moving average of $450.05. Intuitive Surgical, Inc. has a 1-year low of $269.49 and a 1-year high of $525.00. The stock has a market cap of $186.74 billion, a price-to-earnings ratio of 84.29, a price-to-earnings-growth ratio of 4.99 and a beta of 1.39.

Insiders Place Their Bets

In other Intuitive Surgical news, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the sale, the chief executive officer now directly owns 24,219 shares of the company’s stock, valued at approximately $12,391,166.97. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Intuitive Surgical news, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the sale, the chief executive officer now directly owns 24,219 shares of the company’s stock, valued at approximately $12,391,166.97. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Robert Desantis sold 240 shares of Intuitive Surgical stock in a transaction that occurred on Monday, August 12th. The stock was sold at an average price of $464.76, for a total transaction of $111,542.40. Following the completion of the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,558,968.56. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 68,246 shares of company stock valued at $33,839,308. Company insiders own 0.90% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.